Scientists Criticize ‘Rushed’ Approval Of Indian COVID-19 Vaccine Without Efficacy Data-Science Magazine

India’s drug regulator approved two COVID-19 vaccines on 3 January, a decision Prime Minister Narendra Modi hailed on Twitter as “a decisive turning point to strengthen a spirited fight!” against the pandemic and a testament to the Indian scientific community’s self reliance. But some scientists and patient advocates are sharply critical of the move—in particular, the decision to greenlight Covaxin, a vaccine developed in India by Bharat Biotech, without awaiting the results of a phase III trial to determine efficacy and safety. Science Magazine, 01/05/2021

•   Print
•   Email
•   Share
•   Tweet